Cellectar Biosciences Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Cellectar Biosciences Inc.

Cellectar Biosciences Inc. | Key People and Executives

Douglas J. Swirsky

Chairman

James V. Caruso

President, Chief Executive Officer & Director

Frederick W. Driscoll

Independent Director

Stephen Anthony Hill

Independent Director

John P. Neis

Independent Director

Stefan D. Loren

Independent Director

Douglas J. Swirsky

Chairman

James V. Caruso

President, Chief Executive Officer & Director

Brian M. Posner

Chief Financial Officer

John Friend

Chief Medical Officer & Vice President

Jarrod Longcor

Chief Business Officer

Gregory J. Lynch

Secretary

Frederick W. Driscoll

Independent Director

Stephen Anthony Hill

Independent Director

John P. Neis

Independent Director

Stefan D. Loren

Independent Director

View Profile

Address	100 Campus Drive Florham Park New Jersey 07932 United States
Employees	-
Website	http://www.cellectar.com
Updated	07/08/2019
Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micrometastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on April 11, 2011 and is headquartered in Madison, WI.